Teva Pharmaceutical Industries Limited (TLV:TEVA)
6,640.00
+200.00 (3.11%)
Oct 5, 2025, 3:49 PM IDT
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
1.51M ILS
Profits / Employee
-14.30K ILS
Market Cap
75.93B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35,686 | -786 | -2.16% |
Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
Dec 31, 2022 | 35,125 | -854 | -2.37% |
Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Danel (Adir Yeoshua) | 4,290 |
Kamada | 420 |
Bait Bakfar | 227 |
BrainsWay | 120 |
SofWave Medical | 126 |
Ilex Medical | 178 |
Novolog (Pharm-Up 1966) | 936 |
Bonus BioGroup | 49 |
Teva Pharmaceutical Industries News
- 2 days ago - FDA Initiative May Impact Teva's (TEVA) Generic Drug Endeavors - GuruFocus
- 2 days ago - JP Morgan Maintains Overweight Rating on TEVA, Price Target Raised to $26 | TEVA Stock News - GuruFocus
- 5 days ago - Unpacking the Latest Options Trading Trends in Teva Pharmaceutical Indus - Benzinga
- 5 days ago - Notable ETF Inflow Detected - IXUS, PDD, NU, TEVA - Nasdaq
- 10 days ago - Teva Releases Q3 2025 Aide Memoire - GlobeNewsWire
- 10 days ago - Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025 - GlobeNewsWire
- 10 days ago - Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors - Seeking Alpha
- 10 days ago - November 7th Options Now Available For Teva Pharmaceutical Industries (TEVA) - Nasdaq